SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Huaizhong Health Group, Inc. – ‘10-Q’ for 1/31/21 – ‘EX-32.1’

On:  Wednesday, 4/7/21, at 2:58pm ET   ·   For:  1/31/21   ·   Accession #:  1640334-21-798   ·   File #:  0-55369

Previous ‘10-Q’:  ‘10-Q’ on 8/10/20 for 7/31/20   ·   Next:  ‘10-Q’ on 6/14/21 for 4/30/21   ·   Latest:  ‘10-Q’ on 5/26/23 for 1/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/07/21  Huaizhong Health Group, Inc.      10-Q        1/31/21   25:813K                                   Pubco Reporting … Inc/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    173K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     14K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     10K 
10: R1          Cover                                               HTML     61K 
11: R2          Balance Sheets                                      HTML     44K 
12: R3          Balance Sheets (Parenthetical)                      HTML     18K 
13: R4          Statements of Operations (Unaudited)                HTML     42K 
14: R5          Statements of Changes in Stockholders Deficit       HTML     20K 
                (Unaudited)                                                      
15: R6          Statements of Cash Flows (Unaudited)                HTML     33K 
16: R7          Summary of Significant Accounting Policies          HTML     16K 
17: R8          Going Concern                                       HTML     14K 
18: R9          Related Party Transactions                          HTML     13K 
19: R10         Summary of Significant Accounting Policies          HTML     20K 
                (Policies)                                                       
20: R11         Going Concern (Details Narrative)                   HTML     12K 
21: R12         Related Party Transactions (Details Narrative)      HTML     12K 
23: XML         IDEA XML File -- Filing Summary                      XML     34K 
 9: XML         XBRL Instance -- huaizhong_10q_htm                   XML    113K 
22: EXCEL       IDEA Workbook of Financial Reports                  XLSX     18K 
 6: EX-101.CAL  XBRL Calculations -- abcd-20210131_cal               XML     45K 
 8: EX-101.DEF  XBRL Definitions -- abcd-20210131_def                XML     40K 
 5: EX-101.LAB  XBRL Labels -- abcd-20210131_lab                     XML    188K 
 7: EX-101.PRE  XBRL Presentations -- abcd-20210131_pre              XML    132K 
 4: EX-101.SCH  XBRL Schema -- abcd-20210131                         XSD     36K 
24: JSON        XBRL Instance as JSON Data -- MetaLinks               63±    86K 
25: ZIP         XBRL Zipped Folder -- 0001640334-21-000798-xbrl      Zip     38K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Huaizhong Health Group, Inc., (the “Company”) on Form 10-Q for the period ended January 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yuantong Wang, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that;

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

   

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

/s/ Yuantong Wang

Name: Yuantong Wang

Title: Chief Executive Officer and Chief Financial Officer

Date: April 7, 2021


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:4/7/21
For Period end:1/31/21NT 10-Q
 List all Filings 
Top
Filing Submission 0001640334-21-000798   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 10:32:41.1am ET